Justin Dye

This profile gathers the share dealings of Justin Dye in Medicine Man Technologies, Inc., where the filings describe the role as chief executive. Between 5 June 2019 and 28 June 2024, the trades on record add up to 21 filings.

The open-market record is one-sided, with 5 purchases worth €10.7M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 16 share grants. Since January 2024: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €702k. The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The newest entry dates from 2 July 2024: a share grant, in Medicine Man Technologies, Inc. The last purchase on record was published on 15 February 2024, which is 982 days ago. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.